Pages that link to "Q43684872"

The following pages link to Temozolomide chemotherapy in recurrent oligodendroglioma (Q43684872):

Displaying 38 items.

• Temozolomide and radiation in low-grade and anaplastic gliomas: temoradiation (Q30444816) (← links)
• Survival following reirradiation using intensity-modulated radiation therapy with temozolomide in selected patients with recurrent high grade gliomas (Q31033595) (← links)
• Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features. (Q33186142) (← links)
• Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study (Q33358921) (← links)
• Temozolomide: a milestone in neuro-oncology and beyond? (Q33372340) (← links)
• Multi-institutional phase II study of temozolomide administered twice daily in the treatment of recurrent high-grade gliomas (Q33378539) (← links)
• Is there a place for radiotherapy in low-grade gliomas? (Q33526614) (← links)
• Phase II trial of temozolomide and reirradiation using conformal 3D-radiotherapy in recurrent brain gliomas (Q34358041) (← links)
• Novel chemotherapeutic approaches to brain tumors (Q34480131) (← links)
• Oligodendrogliomas: An update on basic and clinical research (Q35105809) (← links)
• Oligodendroglioma and anaplastic oligodendroglioma: clinical features, treatment, and prognosis (Q35565841) (← links)
• Treatment-related myelodysplasia in patients with primary brain tumors (Q35914531) (← links)
• Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: long term results of RTOG BR0131. (Q36096036) (← links)
• Optimal role of temozolomide in the treatment of malignant gliomas. (Q36113030) (← links)
• Postoperative radiotherapy and chemotherapy in the management of oligodendroglioma: single institutional review of 88 patients. (Q36245102) (← links)
• Oligodendroglial tumors (Q36453277) (← links)
• Chemotherapy in the treatment of malignant gliomas (Q36499238) (← links)
• Phase II trial of preirradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: RTOG BR0131 (Q37284303) (← links)
• Anaplastic glioma: current treatment and management (Q38456018) (← links)
• Extended exposure to alkylator chemotherapy: delayed appearance of myelodysplasia (Q40016809) (← links)
• Impact of chromosome 1p status in response of oligodendroglioma to temozolomide: preliminary results (Q44390093) (← links)
• Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomas (Q44768519) (← links)
• Temozolomide as first-line agent in treating high-grade gliomas: phase II study. (Q44835986) (← links)
• Neoadjuvant chemotherapy for symptomatic non operable grade II fibrillary astrocytoma in adults (Q44990078) (← links)
• Temozolomide and Reirradiation in Recurrent Grade II Brain Glioma. (Q45166511) (← links)
• Temozolomide in pediatric low-grade glioma (Q48127890) (← links)
• A Case of Therapy-Related Acute Myeloid Leukemia Associated with Adjuvant Temozolomide Chemotherapy for Anaplastic Astrocytoma (Q48265673) (← links)
• SEOM guideline for the treatment of malignant glioma (Q48464940) (← links)
• Future trends in the treatment of brain tumours (Q48705272) (← links)
• Clinicopathologic features of small cell glioblastomas. (Q49058205) (← links)
• Spinal cord anaplastic oligodendroglioma with 1p deletion: report of a relapsing case treated with temozolomide (Q55463545) (← links)
• [Place of chemotherapy and radiotherapy in the management of oligodendrogliomas] (Q55470792) (← links)
• Resection and Immunotherapy for Recurrent Grade III Glioma (Q58691159) (← links)
• Small cell astrocytoma: An aggressive variant that is clinicopathologically and genetically distinct from anaplastic oligodendroglioma (Q61829495) (← links)
• Oligodendroglioma (Q79222530) (← links)
• Brain tumors (Q80510571) (← links)
• Primary brain tumours in adults (Q90643353) (← links)
• Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trial (Q90986735) (← links)